REGENEREX PHARMA, INC. Deferred Tax Assets, Net of Valuation Allowance, Current
REGENEREX PHARMA, INC. had Deferred Tax Assets, Net of Valuation Allowance, Current of $5.20 thousand as of 2018-03-31, per its 10-K filed 2018-06-21.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2018-06-21
- 2018-03-31: Deferred Tax Assets, Net of Valuation Allowance, Current $5.20K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2018-03-31 | $5.20K 10-K · filed 2018-06-21 |